Risk reduction and health promotion behaviors following genetic testing for adult-onset disorders
作者： Theresa A. Beery , Janet K. Williams
关键词:
摘要: Although clinical genetic testing is available for over 1,000 inherited disorders, consequences of predictive have been most extensively examined hereditary breast and ovarian cancer (HBOC), colon cancer, Huntington disease (HD). These focus primarily on psychological, ethical, legal, social aspects testing. Genetic may also provide information that can lead to behaviors promote health reduce risk disease, reflecting options the disorder which person at risk. However, regardless condition, people completing a test inform relatives about results implications their develop condition. Literature reduction communication focuses families with HBOC or colorectal cancer. Few reports document other conditions. This paper presents systematic review research literature promotion follow...
core.ac.uk
liebertonline.com参考文章(100)
Peter Beighton, Greta Beighton, de la Chapelle, A. The Person Behind the Syndrome. pp. 209- 209 ,(1997) , 10.1007/978-1-4471-0925-9_118
, Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Annals of Internal Medicine. ,vol. 143, pp. 355- ,(2005) , 10.7326/0003-4819-143-5-200509060-00011
Susan Sobel, D. Brookes Cowan, The Process of Family Reconstruction after DNA Testing for Huntington Disease Journal of Genetic Counseling. ,vol. 9, pp. 237- 251 ,(2000) , 10.1023/A:1009416021896
Alan J. Stolier, Ralph L. Corsetti, Newly Diagnosed Breast Cancer Patients Choose Bilateral Mastectomy Over Breast-Conserving Surgery When Testing Positive for a BRCA1/2 Mutation American Surgeon. ,vol. 71, pp. 1031- 1033 ,(2005) , 10.1177/000313480507101209
Narod Sa, Metcalfe Ka, Byrski T, Rzepka-Górska I, Menkiszak J, Gronwald J, Jakubowska A, Lubiński J, Huzarski T, Górski B, Attitudes toward preventive oophorectomy among BRCA1 mutation carriers in Poland. European Journal of Gynaecological Oncology. ,vol. 25, pp. 93- 95 ,(2004)
Douglas F Easton, Familial risks of breast cancer Breast Cancer Research. ,vol. 4, pp. 179- 181 ,(2002) , 10.1186/BCR448
Christine Lasset, Françoise Desseigne, Valérie Bonadona, Alain Puisieux, Jean-Christophe Saurin, Hervé Mignotte, Qing Wang, Gilles Freyer, Henri Plauchu, Pierre Saltel, Olga Sinilnikova, Sophie Giraud, Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result. Cancer Epidemiology, Biomarkers & Prevention. ,vol. 11, pp. 97- 104 ,(2002)
S Creighton, EW Almqvist, D MacGregor, B Fernandez, H Hogg, J Beis, JP Welch, C Riddell, R Lokkesmoe, M Khalifa, J MacKenzie, A Sajoo, S Farrell, F Robert, A Shugar, A Summers, W Meschino, D Allingham-Hawkins, T Chiu, A Hunter, J Allanson, H Hare, J Schween, L Collins, S Sanders, C Greenberg, S Cardwell, E Lemire, P MacLeod, MR Hayden, Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000. Clinical Genetics. ,vol. 63, pp. 462- 475 ,(2003) , 10.1034/J.1399-0004.2003.00093.X
Kenneth P. Tercyak, Chanita Hughes, David Main, Carrie Snyder, Jane F. Lynch, Henry T. Lynch, Caryn Lerman, Parental communication of BRCA1/2 genetic test results to children. Patient Education and Counseling. ,vol. 42, pp. 213- 224 ,(2001) , 10.1016/S0738-3991(00)00122-1
Anja Wagner, Ingrid van Kessel, Mieke G. Kriege, Carli M. J. Tops, Juul Th. Wijnen, Hans F. A. Vasen, Conny A. van der Meer, Iris I. H. van Oostrom, Hanne Meijers-Heijboer, Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures. Familial Cancer. ,vol. 4, pp. 295- 300 ,(2005) , 10.1007/S10689-005-0658-9